
Orsocef-S 750 Injection
Marketer
Orsova Healthcare
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Orsocef-S 750 Injection
Cefixime and Sulbactam injection (750mg) is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration must be strictly under medical guidance. Consistent adherence to the prescribed schedule is crucial; complete the entire course regardless of symptom improvement. Premature cessation may compromise therapeutic effectiveness. Commonly reported adverse effects include nausea, vomiting, diarrhea, and dyspepsia. Escalation of any side effect warrants immediate medical attention. Seek urgent medical help for allergic reactions such as rash, pruritus, edema, or dyspnea. Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased somnolence. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration are recommended for optimal recovery. Your physician may order blood tests and imaging to monitor treatment response.
Uses of Orsocef-S 750 Injection
Infections caused by bacteria
Major Benefits of Orsocef-S 750 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Orsocef-S 750 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Orsocef-S 750 Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Orsocef-S 750 Injection works:
The injectable formulation Orsocef-S 750 combines the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Orsocef-S 750 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Orsocef-S 750 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Orsocef-S 750 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Injection of Orsocef-S 750 might cause drowsiness, visual disturbances, and dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Orsocef-S 750 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Orsocef-S 750 Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Altering the Orsocef-S 750 Injection dosage is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Orsocef-S 750 Injection :
Should you inadvertently omit a dose of Orsocef-S 750 Injection, seek medical advice.
Facts to Know About Orsocef-S 750 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
